Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Respiratory Medicine
Published September 11, 2026
Activin Pathway Inhibition and Rapid Progression of Malignancy in Pulmonary Arterial Hypertension...
September 12, 2026
Medspoke
Medspoke
Thorax
Published September 11, 2026
00:00
--:--
Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.
September 12, 2026
Share
Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.
https://www.medspoke.co/channel_journal?id=740&tap_id=13818
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
European Journal of Heart Failure
Published September 11, 2026
Phenotype-specific prognostic implications of pulse pressure in heart failure.
September 12, 2026
Why are you reporting this TALK?
